# A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

> **NCT02448173** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Vaccinogen Inc** · enrollment: 550 (estimated)

## Conditions studied

- Stage II Colon Cancer

## Interventions

- **BIOLOGICAL:** OncoVAX and Surgery
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT02448173
- **Lead sponsor:** Vaccinogen Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2031-08
- **Final completion:** 2033-08
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448173, "A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02448173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*